Related Experiment Video
Updated: Jul 2, 2025

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Fibrinolysis Resistance After Injury Is a Risk Factor for a Hospital-Acquired Pneumonia-Like Disease Pattern
Ivan E Rodriguez1,2, Jessica L Saben1,2, Ernest E Moore2,3
1Colorado Center for Transplantation Care, Research, and Education (CCTCARE), University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Fibrinolysis resistance, measured by tPA-TEG LY30, is a significant early indicator for pneumonia risk in ICU patients. A LY30 cutoff of less than 4% within 48 hours predicts increased pneumonia rates.
Area of Science:
- Critical Care Medicine
- Hemostasis and Thrombosis
- Infectious Diseases
Background:
- Pneumonia in the intensive care unit (ICU) leads to increased morbidity and costs.
- Early identification of pneumonia risk is crucial for patient outcomes, but reliable early biomarkers are lacking.
- Fibrinolysis resistance (FR) has been suggested as a potential risk factor for infection post-surgery.
Purpose of the Study:
- To evaluate fibrinolysis resistance (FR) as an early predictor of pneumonia in ICU patients.
- To determine the optimal cutoff for tPA-TEG LY30 indicative of increased pneumonia risk.
- To validate the association between FR and pneumonia in different ICU patient cohorts.
Main Methods:
- Patients from a hemorrhagic shock trial were assessed for FR using thrombelastography with exogenous tissue plasminogen activator (tPA-TEG) at 24 and 48 hours post-injury.
- The LY30 parameter was measured to quantify FR.
- Receiver-operating characteristic (ROC) curve analysis identified the optimal LY30 cutoff, which was then validated in ICU patients at risk for venous thromboembolism (VTE) and traumatic brain injury.
Main Results:
- A tPA-TEG LY30 of less than 4% at 24 and 48 hours was identified as the optimal cutoff for predicting increased pneumonia risk.
- In the hemorrhagic shock cohort, this cutoff was associated with a seven-fold increase in pneumonia rates.
- Validation cohorts (VTE and traumatic brain injury) showed similar associations, with the tPA-TEG LY30 cutoff predicting a 10-fold and 11-fold increase in pneumonia, respectively. The association remained significant after adjusting for confounders (aOR, 35.7).
Conclusions:
- Fibrinolysis resistance, quantified by tPA-TEG LY30 within 48 hours of ICU admission, is a significant risk factor for developing pneumonia.
- The identified tPA-TEG LY30 cutoff of <4% can aid in early pneumonia risk stratification for ICU patients.
- Further research is warranted to explore the causal link between endogenous FR and altered immunity in the context of pneumonia development.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-III
Clot Retraction and Fibrinolysis

